Around 3.1 to 3.8% of patients discontinued the treatment due to gastrointestinal side effects
With a dedicated team of well-trained agents, all queries receive quick and helpful responses within 24-48 hours
Fluid retention and heart failure can occur with concomitant use of thiazolidinediones (TZDs), which are PPAR-gamma agonists, and insulin, including Fiasp
The main mechanisms include: The strongest outcomes usually occur when GLP-1 medication is combined with protein-focused nutrition, resistance training, walking, sleep improvement, hydration, stress management, and regular physician monitoring
It has also been approved by the FDA (2019) and EMA (2020) in a tablet form (Rybelsus ), but currently only for treatment of T2DM [28,47]
Together, these processes help rebuild damaged tissue more efficiently while reducing inflammation